Cardiovascular Drugs Market Research Report, Growth & Forecast

The Global Homozygous Familial Hypercholesterolemia (HoFH) Market is projected to expand from USD 94.78 Million in 2025 to USD 111.01 Million by 2031, demonstrating a Compound Annual Growth Rate (CAGR...

The global market for Metoprolol Succinate, a beta1-selective adrenoceptor blocker used to manage hypertension, angina pectoris, and chronic heart failure by regulating heart rate and cardiac output,...

The Global Simvastatin Market is projected to grow from USD 150.19 Million in 2025 to USD 237.14 Million by 2031, achieving a 7.91% CAGR. Simvastatin, a widely prescribed HMG-CoA reductase inhibitor,...

The global Kounis Syndrome Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Kounis syndrome, also kno...

The global Chronic Pulmonary Hypertension Drug market size is predicted to grow from US$ 7119 million in 2025 to US$ 10280 million in 2032; it is expected to grow at a CAGR of 5.5% from 2026 to 2032....

The global Chronic Pulmonary Hypertension Treatment market size is predicted to grow from US$ 7119 million in 2025 to US$ 10280 million in 2032; it is expected to grow at a CAGR of 5.5% from 2026 to 2...

The global Severe Hypertriglyceridemia (SHTG) Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The gl...

The global Ventricular Fibrillation Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The global pharm...

The global Cerebral Vein Thrombosis Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The global pharm...

The global Chemical Lipid-Lowering Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Chemical Lipid-Lowerin...

The global Prinzmetal Angina Therapeutics market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The global pharmaceu...

The global Restrictive Cardiomyopathy Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The global pha...

The global Takotsubo Syndrome Therapeutics market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The global pharmace...

According to our (Global Info Research) latest study, the global Rheumatic-Heart Disease Management market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by...

The global Postural Orthostatic Tachycardia Syndrome Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032....

The global Stroke Prevention in Atrial Fibrillation Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032....

The global Acute Ischemic Stroke Therapeutics Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United Sta...

According to Stratistics MRC, the Global Takotsubo Syndrome Therapeutic Market is accounted for $0.52 billion in 2026 and is expected to reach $0.99 billion by 2034 growing at a CAGR of 8.3% during th...

The global Selective Cardiac Myosin Inhibitors market size is predicted to grow from US$ 815 million in 2025 to US$ 1770 million in 2032; it is expected to grow at a CAGR of 12.0% from 2026 to 2032. I...

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics i...

Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piper...

Calcium channel blockers?CCBs? are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and inc...

Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon and other diseases in which the blood vessels are constricted and blood can't flow to the tiss...

Cardiovascular disease (CVD) is the leading cause of death in the world. The number of people who die of cardiovascular disease is the largest every year. Cardiovascular drugs are used to treat cardio...

Nadolol, sold under the brand name Corgard among others, is a medication used to treat high blood pressure, heart pain, and atrial fibrillation. It has also been used to prevent migraine headaches and...

Angina pectoris is a clinical indication characterized by precordial heaviness or discomfort due to transient myocardial ischemia without infarction, elicited by physical exertion or psychological str...

Arollol hydrochloride tablets are third-generation ? receptor blockersThe global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutica...

Treprostinil is a vasodilator that is used for the treatment of pulmonary arterial hypertension.Treprostinil is a medication used for the treatment of pulmonary arterial hypertension (PAH), a conditio...

Beraprost sodium (beraprost) is a stable, orally active prostacyclin analogue with vasodilatory, antiplatelet and cytoprotective effects.The Beraprost Sodium market is driven by the rising prevalence...

Moexipril an angiotensin converting enzyme inhibitor (ACE inhibitor) used for the treatment of hypertension and congestive heart failureThe global pharmaceutical market is 1475 billion USD in 2022, gr...

Epoprostenol sodium directly simulates prostaglandin receptors in arterial vascular smooth muscle, thereby causing vasodilatation.The Epoprostenol Sodium FDF (Finished Dosage Form) market is driven by...

Epoprostenol sodium directly simulates prostaglandin receptors in arterial vascular smooth muscle, thereby causing vasodilatation.The Epoprostenol Sodium FDF (Finished Dosage Form) market is driven by...

Natriuretic peptides are hormones produced by the heart and other tissues in response to increased blood volume and pressure. They play a role in regulating blood pressure, fluid balance, and cardiac...

Dihydropyridine calcium channel blockers (DHP-CCBs) are a class of medications that selectively inhibit L-type calcium channels in vascular smooth muscle, leading to vasodilation and reduced blood pre...

Dihydropyridine vasodilators are a subclass of calcium channel blockers that primarily act on vascular smooth muscle to induce vasodilation by inhibiting L-type calcium channels. They are widely used...

General medicines for myocarditis refer to a range of medications commonly used to treat the inflammation of the heart muscle and manage its underlying causes and complications. These include anti-inf...

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strateg...

Carvedilol is a beta-blocker. Beta-blockers affect the heart and circulation (blood flow through arteries and veins). Carvedilol is used to treat heart failure and hypertension (high blood pressure)....

Nifedipine Injection is a calcium channel blocker (CCB) used primarily for the rapid reduction of blood pressure in hypertensive emergencies and certain cardiovascular conditions. It works by relaxing...

According to our (Global Info Research) latest study, the global Nebivolol Hydrochloride API market size was valued at US$ 669 million in 2025 and is forecast to a readjusted size of US$ 844 million b...

According to our (Global Info Research) latest study, the global Pentoxifylline API market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAG...

According to our (Global Info Research) latest study, the global Pharmaceutical Grade Ambrisentan market size was valued at US$ 838 million in 2025 and is forecast to a readjusted size of US$ 1128 mil...

According to our (Global Info Research) latest study, the global Pharmaceutical Grade Indobufen market size was valued at US$ 223 million in 2025 and is forecast to a readjusted size of US$ 283 millio...

According to our (Global Info Research) latest study, the global Pharmaceutical Grade Ticagrelor market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 20...

The global Acute Coronary Syndrome Therapeutic market size is predicted to grow from US$ 8483 million in 2025 to US$ 13647 million in 2032; it is expected to grow at a CAGR of 7.1% from 2026 to 2032....

The global Anti-ANGPTL3 Antibody Drugs market size is predicted to grow from US$ 145 million in 2025 to US$ 295 million in 2032; it is expected to grow at a CAGR of 10.0% from 2026 to 2032. In 2025, g...

The global Anti-ANGPTL3 Antibody Lipid-lowering Drugs market size is predicted to grow from US$ 150 million in 2025 to US$ 284 million in 2032; it is expected to grow at a CAGR of 9.3% from 2026 to 20...

Pulmonary Edema Therapeutics Market reached USD 3.8 billion in 2025 and is expected to reach USD 6.2 billion by 2033, growing with a CAGR of 6.80% during the forecast period 2026-2033. The Pulmonary E...

Global Pulmonary Arterial Hypertension Treatment Market valued at USD 8.02 billion in 2025 is anticipated to reach USD 15.07 billion by 2036, growing at 5.90% CAGR during forecast period. As a matter...

Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Marketis is growing with a CAGR of 35.30% during the forecast period 2026-2035. The Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market emerges as a ke...